Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001193125-26-463787

Chief Financial Officer bought 20,000 shares at $0.86 ($17,100)

From the SEC's structured data for this filing

Trades in this filing

Howe Jill Ann · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Purchase : show line 1 in the form +20,000 $0.86 $17,100 45,500 D
Open-market purchases · 20,000 sh · avg $0.86 · $17,100
Loading xslF345X06/ownership.xml…